WAGENER, Nina, MACHER-GOEPPINGER, Stephan, PRITSCH, Maria, HÜSING, Johannes, HOPPE-SEYLER, Karin, SCHIRMACHER, Peter, PFITZENMAIER, Jesco, HAFERKAMP, Axel, HOPPE-SEYLER, Felix und HOHENFELLNER, Markus, 2010. Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma. BMC cancer. 2010. No. Band 10 (04.10. 2010), p. Band 10 (04.10. 2010). DOI 10.1186/1471-2407-10-524.
Elsevier - Harvard (with titles)Wagener, N., Macher-Goeppinger, S., Pritsch, M., Hüsing, J., Hoppe-Seyler, K., Schirmacher, P., Pfitzenmaier, J., Haferkamp, A., Hoppe-Seyler, F., Hohenfellner, M., 2010. Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma. BMC cancer Band 10 (04.10. 2010). https://doi.org/10.1186/1471-2407-10-524
American Psychological Association 7th editionWagener, N., Macher-Goeppinger, S., Pritsch, M., Hüsing, J., Hoppe-Seyler, K., Schirmacher, P., Pfitzenmaier, J., Haferkamp, A., Hoppe-Seyler, F., & Hohenfellner, M. (ca. 2010). Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma [Electronic]. BMC cancer, Band 10 (04.10. 2010), Band 10 (04.10. 2010). https://doi.org/10.1186/1471-2407-10-524
Springer - Basic (author-date)Wagener N, Macher-Goeppinger S, Pritsch M, Hüsing J, Hoppe-Seyler K, Schirmacher P, Pfitzenmaier J, Haferkamp A, Hoppe-Seyler F, Hohenfellner M (2010) Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma. BMC cancer Band 10 (04.10. 2010). https://doi.org/10.1186/1471-2407-10-524
Juristische Zitierweise (Stüber) (Deutsch)Wagener, Nina/ Macher-Goeppinger, Stephan/ Pritsch, Maria/ Hüsing, Johannes/ Hoppe-Seyler, Karin/ Schirmacher, Peter/ Pfitzenmaier, Jesco/ Haferkamp, Axel/ Hoppe-Seyler, Felix/ Hohenfellner, Markus, Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma, BMC cancer 2010, Band 10 (04.10. 2010).